(Q46968943)

27 December 2017

title

Choline kinase alpha in cancer prognosis and treatment (English)

1 reference

27 December 2017

author name string

Kristine Glunde

series ordinal

1

1 reference

27 December 2017

Zaver M Bhujwalla

series ordinal

2

1 reference

27 December 2017

publication date

1 October 2007

1 reference

27 December 2017

Lancet Oncology Commission

published in

1 reference

27 December 2017

volume

8

1 reference

27 December 2017

issue

10

1 reference

27 December 2017

page(s)

855-857

1 reference

27 December 2017

Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Alterations of choline phospholipid metabolism in ovarian tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Structure and function of choline kinase isoforms in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Choline metabolism in cancer: implications for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970289-9

7 January 2021

10.1016/S1470-2045(07)70289-9

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017